[go: up one dir, main page]

NO20080158L - Oyedraper som inneholder roflumilast - Google Patents

Oyedraper som inneholder roflumilast

Info

Publication number
NO20080158L
NO20080158L NO20080158A NO20080158A NO20080158L NO 20080158 L NO20080158 L NO 20080158L NO 20080158 A NO20080158 A NO 20080158A NO 20080158 A NO20080158 A NO 20080158A NO 20080158 L NO20080158 L NO 20080158L
Authority
NO
Norway
Prior art keywords
roflumilast
oyadraper
containing roflumilast
efficiency
increased
Prior art date
Application number
NO20080158A
Other languages
English (en)
Inventor
Yoko Endo
Aiko Kimura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20080158L publication Critical patent/NO20080158L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det tilveiebringes øyedråper inneholdende roflumilast som aktiv bestanddel med økt effektivitet. Ved innføring av minst en type viskositetsøkende middel i øyedråpen inneholdende roflumilast som en effektiv bestanddel, kan det fremstilles en øyedråpe der effektiviteten for roflumilast er økt.
NO20080158A 2005-06-09 2008-01-09 Oyedraper som inneholder roflumilast NO20080158L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005169015 2005-06-09
PCT/JP2006/311576 WO2006132342A1 (ja) 2005-06-09 2006-06-09 ロフルミラスト点眼液

Publications (1)

Publication Number Publication Date
NO20080158L true NO20080158L (no) 2008-03-04

Family

ID=37498536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080158A NO20080158L (no) 2005-06-09 2008-01-09 Oyedraper som inneholder roflumilast

Country Status (8)

Country Link
US (1) US20090209599A1 (no)
EP (1) EP1889620A4 (no)
KR (1) KR20080029974A (no)
CN (1) CN101193634A (no)
CA (1) CA2610881A1 (no)
NO (1) NO20080158L (no)
RU (1) RU2007149249A (no)
WO (1) WO2006132342A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130274332A1 (en) * 2010-12-17 2013-10-17 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition for contact lens
CN102793684B (zh) * 2011-05-26 2016-02-17 杭州赛利药物研究所有限公司 罗氟司特液体制剂及其制备方法
CN103764168B (zh) * 2011-07-08 2016-02-17 乐敦制药株式会社 水性眼科用组合物
JP6462201B2 (ja) * 2012-06-14 2019-01-30 ロート製薬株式会社 水性眼科組成物
JP5988855B2 (ja) 2012-06-27 2016-09-07 ロート製薬株式会社 水性眼科組成物
US8980839B2 (en) 2012-08-24 2015-03-17 Ocular Technologies Sarl Topical aqueous nanomicellar, ophthalmic solutions and uses thereof
WO2017064731A1 (en) 2015-10-16 2017-04-20 Sun Pharma Advanced Research Company Limited Ophthalmic solution of difluprednate
EP4364810A3 (en) 2015-11-10 2024-07-24 Sun Pharmaceutical Industries Limited Topical formulations and uses thereof
JP7072517B2 (ja) 2016-02-29 2022-05-20 サン ファーマ グローバル エフゼットイー 局所用シクロスポリン含有製剤およびその使用
JP2024501425A (ja) * 2020-12-03 2024-01-12 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 眼炎症の有害作用を軽減するためのジフルプレドナート
AU2022218993A1 (en) 2021-02-10 2023-08-03 Iolyx Therapeutics, Inc. Methods for ophthalmic delivery of roflumilast
CN116867480A (zh) * 2021-02-10 2023-10-10 洛利克斯治疗有限公司 眼部递送罗氟司特的方法
EP4405048A4 (en) * 2021-09-22 2025-08-06 Iolyx Therapeutics Inc METHODS OF TREATMENT OF INFLAMMATORY EYE DISEASES
EP4587015A1 (en) * 2022-09-16 2025-07-23 Iolyx Therapeutics, Inc. High concentration pharmaceutical compositions of roflumilast for ophthalmic delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
ES2098739T3 (es) * 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
SI0706513T1 (en) * 1993-07-02 2002-10-31 Altana Pharma Ag Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
JP2002543133A (ja) * 1999-05-04 2002-12-17 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング ロフルミラストおよびｐｄｅ−３インヒビターを含有する共力薬の組合せ物
SI2020243T1 (sl) * 2002-05-28 2018-11-30 Astrazeneca Ab Farmacevtski pripravek za topično uporabo

Also Published As

Publication number Publication date
WO2006132342A1 (ja) 2006-12-14
RU2007149249A (ru) 2009-07-20
CN101193634A (zh) 2008-06-04
EP1889620A1 (en) 2008-02-20
KR20080029974A (ko) 2008-04-03
US20090209599A1 (en) 2009-08-20
CA2610881A1 (en) 2006-12-14
EP1889620A4 (en) 2008-12-10

Similar Documents

Publication Publication Date Title
NO20080158L (no) Oyedraper som inneholder roflumilast
NO20083630L (no) Nye pyridinderivater
NO20082793L (no) Nye tiofenderivater
NO20091395L (no) Nye tiofenderivater
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
BRPI0803374A2 (pt) compostos polihidróxi como agentes de extinção de polimerização
NO20083462L (no) Nye tiofenderivater som S1P1/EDG1-reseptoragonister
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EP3542629A3 (en) Dithiol compounds, derivatives, and uses therefor
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
NO20076648L (no) Novel thiophene derivatives
MX2009009290A (es) Compuestos activos en ppar.
WO2009137391A3 (en) Benzene sulfonamide thiazole and oxazole compounds
UY33397A (es) Forma sólida de un naftaleno carboxamida
TW200942524A (en) Novel aminomethyl benzene derivatives
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
NO20073033L (no) Cytotoksiske midler innbefattende nye taksaner
WO2011143772A9 (en) Inhibitors of hiv replication
TW200942530A (en) Pyridine compounds
WO2008151828A8 (en) Novel microbiocides
UA106880C2 (uk) Нові гербіциди
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
WO2009051223A1 (ja) 白内障処置のための医薬組成物

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application